IRLAB Therapeutics AB
STO:IRLAB A
IRLAB Therapeutics AB
STO:IRLAB A
Price:
1.526
SEK
-1.55%
Market Cap:
kr129.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
IRLAB Therapeutics AB
STO:IRLAB A
|
SE |
|
W
|
Westwing Comercio Varejista SA
BOVESPA:WEST3
|
BR |
|
G
|
GSE Co Ltd
KOSDAQ:053050
|
KR |
|
Porto Seguro SA
BOVESPA:PSSA3
|
BR |
|
Innovent Biologics Inc
HKEX:1801
|
CN |
|
Chongqing Sansheng Industrial Co Ltd
SZSE:002742
|
CN |
|
M
|
Mitrajaya Holdings Bhd
KLSE:MHB
|
MY |
|
Guangdong Cellwise Microelectronics Co Ltd
SSE:688325
|
CN |
|
B
|
Biotest AG
XETRA:BIO2
|
DE |
|
Cencora Inc
NYSE:COR
|
US |
|
Kirloskar Pneumatic Company Ltd
NSE:KIRLPNU
|
IN |
|
Kam Hing International Holdings Ltd
HKEX:2307
|
HK |
|
Badaro No.19 Ship Investment Co
KRX:155900
|
KR |
|
J
|
Jiangsu Changshu Automotive Trim Group Co Ltd
SSE:603035
|
CN |
|
Gerresheimer AG
XETRA:GXI
|
DE |
|
Jack Henry & Associates Inc
NASDAQ:JKHY
|
US |
|
Airgain Inc
NASDAQ:AIRG
|
US |
|
Garibaldi Resources Corp
XTSX:GGI
|
CA |
|
CSG Systems International Inc
NASDAQ:CSGS
|
US |
|
M
|
MST Golf Group Bhd
KLSE:MSTGOLF
|
MY |
|
M
|
Macmic Science & Technology Co Ltd
SSE:688711
|
CN |
|
Digital China Holdings Ltd
HKEX:861
|
HK |
|
C
|
Coweaver Co Ltd
KOSDAQ:056360
|
KR |
|
BMEX Gold Inc
XTSX:BMEX
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
IRLAB A
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 1.526 SEK,
IRLAB Therapeutics AB
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IRLAB A Multiples-Based Value
LOCKED
Multiples Across Competitors
IRLAB A Competitors Multiples
IRLAB Therapeutics AB Competitors
IRLAB Therapeutics AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
IRLAB Therapeutics AB
STO:IRLAB A
|
129.6m SEK | 2.3 | -1.2 | -0.8 | -0.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5 | 29 | 16.1 | 22.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
